Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Pycnogenol, a standardized extract from French maritime pine bark (Pinus pinaster), has been investigated for its potential neuroprotective effects, including applications in nerve damage such as diabetic neuropathy. Several small-scale clinical studies and preclinical research suggest that Pycnogenol possesses antioxidant, anti-inflammatory, and microcirculatory-improving properties, which may be beneficial in managing symptoms of nerve damage.

For example, a randomized, controlled trial published in European Review for Medical and Pharmacological Sciences (2006) reported that diabetic patients with neuropathy experienced reduced symptoms and improved microcirculation after supplementation with Pycnogenol. Other studies have found similar benefits, but most have limitations, including small sample sizes and short intervention periods.

Mechanistically, Pycnogenol’s flavonoids are thought to protect nerve cells from oxidative stress and improve endothelial function, potentially reducing the progression of nerve damage. However, systematic reviews and meta-analyses highlight that the available evidence is preliminary, and there is a need for larger, high-quality studies to confirm efficacy and establish safety over the long term.

In summary, while some early scientific studies suggest Pycnogenol may help support nerve function and reduce neuropathic symptoms, the overall evidence is limited and not conclusive. Therefore, its use for nerve damage has some scientific basis, but it is not yet strongly validated.

More about Pycnogenol
More about Nerve Damage

Other ingredients used for Nerve Damage

Other health conditions supported by Pycnogenol

Products containing Pycnogenol